Is IMAX (IMAX) Outperforming Other Consumer Discretionary Stocks This Year?

IMAX

Investors focused on the Consumer Discretionary space have likely heard of IMAX (IMAX - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of IMAX and the rest of the Consumer Discretionary group's stocks.

IMAX is one of 244 individual stocks in the Consumer Discretionary sector. Collectively, these companies sit at #8 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. IMAX is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past three months, the Zacks Consensus Estimate for IMAX's full-year earnings has moved 11.28% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

According to our latest data, IMAX has moved about 7.07% on a year-to-date basis. Meanwhile, stocks in the Consumer Discretionary group have gained about 19.48% on average. As we can see, IMAX is performing better than its sector in the calendar year.

Breaking things down more, IMAX is a member of the Film and Television Production and Distribution industry, which includes 7 individual companies and currently sits at #174 in the Zacks Industry Rank. This group has gained an average of 3.54% so far this year, so IMAX is performing better in this area.

IMAX will likely be looking to continue its solid performance, so investors interested in Consumer Discretionary stocks should continue to pay close attention to the company.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>